Literature DB >> 7572056

Cognitive function and anticonvulsant therapy: effect of monotherapy in epilepsy.

A Sabers1, A Møller, M Dam, A Smed, P Arlien-Søborg, J Buchman, E B Andersen, F Boesen, A M Dam, B B Lyon.   

Abstract

INTRODUCTION: The effect of antiepileptic drugs (AED) on cognitive function was studied in 87 patients with epilepsy.
MATERIAL AND METHODS: Group A: (n = 52) started AED treatment (carbamazepine, oxcarbazepine, sodium-valproate, phenobarbital or phenytoin). Group B: (n = 27) had AED monotherapy withdrawn (carbamazepine or sodium-valproate). Group C: (n = 8) was switched from phenytoin to carbamazepine monotherapy. The patients were tested before and 4 months after change of the treatment.
RESULTS: In group A the test performances were in general unchanged. Patients who had their drug treatment withdrawn (group B) and the patients who were switched from phenytoin to carbamazepine (group C) improved in single tests. The predominant changes in performance seem to be due to practice effect.
CONCLUSION: Cognitive functions are only minimally influenced by AEDs after short-term treatment whereas there is a slight improvement after discontinuation of long-term administration of carbamazepine and valproate. A lack of practice effect might be the first indicator of a negative effect of AED on cognitive function.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7572056     DOI: 10.1111/j.1600-0404.1995.tb00461.x

Source DB:  PubMed          Journal:  Acta Neurol Scand        ISSN: 0001-6314            Impact factor:   3.209


  20 in total

Review 1.  Anticonvulsants and breast feeding: a critical review.

Authors:  B Bar-Oz; I Nulman; G Koren; S Ito
Journal:  Paediatr Drugs       Date:  2000 Mar-Apr       Impact factor: 3.022

Review 2.  Suicidality and antiepileptic drugs: is there a link?

Authors:  Vladimir V Kalinin
Journal:  Drug Saf       Date:  2007       Impact factor: 5.606

Review 3.  Carbamazepine versus phenobarbitone monotherapy for epilepsy: an individual participant data review.

Authors:  Sarah J Nolan; Anthony G Marson; Jennifer Weston; Catrin Tudur Smith
Journal:  Cochrane Database Syst Rev       Date:  2016-12-15

Review 4.  Oxcarbazepine: an update of its efficacy in the management of epilepsy.

Authors:  K Wellington; K L Goa
Journal:  CNS Drugs       Date:  2001       Impact factor: 5.749

Review 5.  Antiepileptic drug-induced cognitive adverse effects: potential mechanisms and contributing factors.

Authors:  Marco Mula; Michael R Trimble
Journal:  CNS Drugs       Date:  2009       Impact factor: 5.749

6.  Cognitive effects of antiepileptic drugs.

Authors:  Sung-Pa Park; Soon-Hak Kwon
Journal:  J Clin Neurol       Date:  2008-09-30       Impact factor: 3.077

7.  Cognitive Effects of Low-dose Topiramate Compared with Oxcarbazepine in Epilepsy Patients.

Authors:  Sun-Young Kim; Ho-Won Lee; Doo-Kyo Jung; Chung-Kyu Suh; Sung-Pa Park
Journal:  J Clin Neurol       Date:  2006-06-20       Impact factor: 3.077

8.  Spotlight on oxcarbazepine in epilepsy.

Authors:  Lynne M Bang; Karen L Goa
Journal:  CNS Drugs       Date:  2004       Impact factor: 5.749

Review 9.  Phenytoin versus valproate monotherapy for partial onset seizures and generalised onset tonic-clonic seizures: an individual participant data review.

Authors:  Sarah J Nolan; Anthony G Marson; Jennifer Weston; Catrin Tudur Smith
Journal:  Cochrane Database Syst Rev       Date:  2016-04-28

Review 10.  Oxcarbazepine: a review of its use in children with epilepsy.

Authors:  Lynne Bang; Karen Goa
Journal:  Paediatr Drugs       Date:  2003       Impact factor: 3.022

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.